Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib plus chemotherapy in squamous NSCLC
NCT02106546Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Apr 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 38
01
Overview
A Phase 3 trial of veliparib in squamous cell carcinoma of the lung (SCCL), sponsored by AbbVie Inc.. Started Apr 2014; status: completed.
02
Drugs
veliparib
03
Conditions
squamous cell carcinoma of the lung (SCCL)
Beyond the preview
Go deeper on NCT02106546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02106546.